Key result
Surgical treatment of pulmonary artery angiosarcoma is linked to a 67% 30-day mortality rate.
Why the study?
Pulmonary artery angiosarcoma is a rare and extremely severe tumor with limited clinical data on surgical treatment outcomes.
What are the clinical outcomes of surgical treatment for pulmonary artery angiosarcoma?
Observational (n=9)
No
What are the clinical outcomes of surgical treatment for pulmonary artery angiosarcoma?
Surgical treatment of pulmonary artery angiosarcoma carries a very high 30-day mortality (67%), highlighting the extreme severity of the disease and the need for expert multidisciplinary care.
No takes yet. Share an insight, caveat, or question.
High mortality supports cautious surgical selection in this rare tumor; leaves open optimal multimodal or nonsurgical strategies.
Edemskiy et al. (2025) conducted an observational in Pulmonary artery angiosarcoma (n=9). Surgical treatment was evaluated on 30-day mortality. Surgical treatment of pulmonary artery angiosarcoma was associated with a 30-day mortality rate of 67% (6 out of 9 patients).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: